Please login to the form below

Not currently logged in
Email:
Password:

MISSION appoints Paul Wallace as chief business officer

Joins from Medivir where he was executive VP and head of business development

edit-Mission-Paul_WallaceCancer biotech MISSION Therapeutics has named Paul Wallace as chief business officer.

Wallace has worked in business development roles within drug discovery companies for almost 20 years, most recently at Medivir where he was executive VP and head of business development as well as member of the executive management team responsible for strategic and operational leadership, R&D portfolio management and investment planning.

Commenting on his appointment, Wallace said: “I am delighted to be joining the MISSION team at a time when the commercialisation of certain assets is an increasingly promising prospect.

“The diversity of assets created is testimony to the rigour of MISSION's screening platform in this critically important, but hitherto difficult, area of drug discovery.”

During his time at Medivir, he played a key role in the execution of over 25 partnership deals, eight products were taken into clinical development and two drugs were launched.

In his new role, Wallace will construct future business strategy, including the potential of development partnerships.

Anker Lundemose, MISSION CEO, added: “Paul's extensive business development experience will be invaluable in helping us find the right strategic partnerships to fully realise the potential of these assets.

“Our core focus is cancer, but our platform discovery approach has yielded highly promising molecules for other indications, such as Parkinson's disease. We see partnering as an attractive option for taking these non-core projects forward.”

17th March 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics